Inhibrx Biosciences is trading at $91.00, up 7.39% during the November 9 session, with broad-market gains offering a likely sentiment context. - Major indexes are up more than 1.5%. - No clear company-specific announcement explaining the move surfaced in available search results; the latest identified company release is dated September 8.